Unsafe Practices Associated with HCV Infection Among Adults: A Case Control Study

Mohamed Heiza, Khaled Elmola, Basem Salama

Abstract


Background: Infection with the hepatitis C virus (HCV) occurs globally. It is a substantial cause of chronic liver disease, cirrhosis and hepatocellular carcinoma. Egypt one the countries that has the highest hepatitis C burden in the world. The occurrence of HCV is directly related to the number of individuals who regularly share injection instruments and to the prevalence of inappropriate parenteral procedures in healthcare facilities. The study aimed to identify unhealthy community practices related to HCV infection.

Methods: a nested case control study carried out in Damietta Governorate, Egypt. Where150 cases (positive for HCV) and 300 controls (negative for HCV) were randomly chosen.

Results: Participant who shared shaving razor was 8.4times more likely to acquire HCV infection followed by IV fluid and needle or sharp stick (about six times more risk).while acupuncture, cupping, tattooing and traditional cauterization carried 1.6 to 3.6 times more risk for HCV infection.

Conclusions: Unhealthy community practices carried a higher risk for acquiring HCV infection. It is highly advocated to strengthen infection prevention and control program in health care facilities and health education programs to enhance community awareness and empowerment.


Keywords


HCV; Infection; practices; risk factors; unsafe

Full Text:

PDF

References


Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C:

Global epidemiology and strategies for control. Clin Microbiol

Infect 2016;22:833‑838.

Babanejad M, Izadi N, Alavian SM. A systematic review and

meta‑analysis on the prevalence of HBsAg in health care workers

from Eastern mediterranean and Middle Eastern countries. Int J

Prev Med 2019;10:144.

World Health Organization [Internet]. Global hepatitis

report; c2017. http://www.who.int/hepatitis/publications/

global‑hepatitis‑report2017/en/. [Last accessed on 2018 Jun 12]

Heymann DL. Control of Communicable Diseases Manual

th edition, An Official Report of the American Public Health

Association. American Public Health Association. New York:

NY Httpajph Aphapublications Orgdoibook 102105CCDM.

:2745.

Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T,

Abubakar I, et al. The global burden of viral hepatitis from 1990

to 2013: Findings from the Global Burden of disease study 2013.

Lancet 2016;388:1081‑18.

Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global

epidemiology of hepatitis C virus infection: New estimates

of age‑specific antibody to HCV seroprevalence. Hepatology

;57:1333‑42.

Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin

Microbiol Infect 2011;17:107‑15.

Petruzziello A, Marigliano S, Loquercio G, Cozzolino A,

Cacciapuoti C. Global epidemiology of hepatitis C virus infection:

An up‑date of the distribution and circulation of hepatitis C virus

genotypes. World J Gastroenterol 2016;22:7824‑40.

Polaris Observatory HCV Collaborators. Global prevalence

and genotype distribution of hepatitis C virus infection in

: A modelling study. Lancet Gastroenterol Hepatol

;2:161‑76.

Saleh LM, Canioni D, Shamaa S, El‑Zaafarany M, Emarah Z,

Abdel‑Aziz S, et al. High prevalence of hepatitis c virus

associated b‑cell lymphoma in Mansoura region (Egypt), ANRS

study. Mediterr J Hematol Infect Dis 2019;11;e2019011.

Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu‑Raddad LJ.

The epidemiology of hepatitis C virus in Egypt: A systematic

review and data synthesis. BMC Infect Dis 2013;13:288.

Kouyoumjian SP, Chemaitelly H, Abu‑Raddad LJ. Characterizing

hepatitis C virus epidemiology in Egypt: Systematic reviews,

meta‑analyses, and meta‑regressions. Sci Rep 2018;8:1661.

Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR,

Magder LS, et al. The role of parenteral antischistosomal

therapy in the spread of hepatitis C virus in Egypt. Lancet

;355:887‑91.

El‑Ghitany EM, Farghaly AG. Geospatial epidemiology of

hepatitis C infection in Egypt 2017 by governorate. Heliyon

;5:e02249.

Miller FD, Abu‑Raddad LJ. Evidence of intense ongoing

endemic transmission of hepatitis C virus in Egypt. Proc Natl

Acad Sci USA 2010;107:14757‑62.

Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I,

Taylor‑Robinson SD. Hepatitis C in Egypt‑Past, present, and

future. Int J Gen Med 2016;10:1‑6.

Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P,

Hajebi A, et al. Hepatitis C virus seroprevalence and associated

risk factors among male drug injectors in Kermanshah, Iran.

Hepat Mon 2017;17:e58739.

Gacche RN, Al‑Mohani SK. Seroprevalence and risk factors for

hepatitis C virus infection among general population in central

region of Yemen. Hepat Res Treat 2012;2012:689726.

Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I,

Habibinejad H, et al. Distribution and risk factors of hepatitis B

virus infection in the general population of Central Iran. Hepat

Mon 2012;12:112‑7.

Averbukh LD, Wu GY. Highlights for dental care as a Hepatitis

C risk factor: A review of literature. J Clin Transl Hepatol

;7:346‑51.

Reker C, Islam KM. Risk factors associated with high

prevalence rates of hepatitis C infection in Egypt. Int J Infect Dis

;25:104‑6.

Al-Kubaisy W, Al-Naggar RA, Shamsidah Ni N,

Bobryshev YV and Al-Kubaisy MW. Is dental extraction a risk

factor for contracting HCV infection: Abs, RNA and genotype

detection? Oral Biol Dent. 2014;2:7.

Abo‑Amer YE‑E, Abd‑Elsalam S, Eldosoky H, ELShenawy AK,

Awny S, Elagawy W, et al. Declining prevalence of hepatitis C

virus among university students in one of the main governorates

in Egypt. Infect Drug Resist 2018;11:2435‑41.

Abd El‑Wahab EW, Mikheal A, Sidkey F, Shatat HZ. Factors

associated with hepatitis C infection among chronic HCV

Egyptian patients. Iran J Public Health 2014;43:1510‑8.

Mohd Suan MA, Said SM, Lim PY, Azman AZ, Abu

Hassan MR. Risk factors for hepatitis C infection among adult

patients in Kedah state, Malaysia: A case–control study. PLoS

One 2019;14:e0224459.

Dahiya P, Kamal R, Sharma V, Kaur S. “Hepatitis”‑Prevention

and management in dental practice. J Educ Health Promot

;4:33.

Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F.

Association of tattooing and hepatitis C virus infection:

A multicenter case‑control study. Hepatology 2013;57:2117‑23.

Khodadost M, Maajani K, Arabsalmani M, Mahdavi N,

Tabrizi R, Alavian SM, et al. Is tattooing a risk factor for

hepatitis C transmission? An updated systematic review and

meta‑analysis. Hepat Mon 2017;17:e14308.

Rezaei N, Amini‑Kafiabad S, Maghsudlu M, Abolghasemi H.

Risk factor analysis of hepatitis C virus seropositivity in

Iranian blood donors: A case‑control study. Transfusion

;56:1891‑8.




ijpm_12_448